You are on the Ceolus Site

Go back to Main Page ➤


Asahi Kasei Ceolus™

Functional Excipients of Asahi Kasei

Developing new paths to broaden your horizons with the functional excipients of Asahi Kasei Europe. Explore our products: Ceolus™, Celphere™ and PC-10.

Asahi Kasei Ceolus™

Ceolus™ of Asahi Kasei Europe

With their extraordinary compactibility, Ceolus™ UF and KG facilitate formulation design and tableting efficiency – for high-dose, small-tablet, and low-compactibility drug implementations.

Make The Smart Choice

The Commitment Of The Asahi Kasei Group:

Asahi Kasei develops cellulose-based pharmaceutical excipients that provide solutions to the challenges of tableting and enable patient-friendly dosage forms.


Go to Ceolus Productpage

High Performance Microcrystalline Cellulose (MCC)


Go to Celphere Productpage

Microcrystalline Cellulose (MCC) Sphere


Go to PC-10 Productpage

Non-soluble Pregelatinized Corn Starch

AK Pharmaceutical Excipients

Pharmaceutical Solutions in Europe

We, Asahi Kasei started our MCC production in 1970 in Nobeoka, a city in the South edge of Japan, which is the birthplace of the Asahi Kasei group. Since the 2000s, we have been continuously developing MCC products that have unique performance which derives from our patented unique morphology design.

tablets on a surface, pharmaceutical excipients

Sample Request Pharmaceutical Excipients

Our products have helped customers with technical challenges among several product development stages such as lab, scale-up, and production. We will keep up the commitment to develop high performance and/or highly functional products that will benefit our customers.

Man, work, tablet, data
map, European map

Distributors of AKEU

Reach Out To Our Distributors

The operational challenges in global pharma are complex, requiring strategic clarity, rapid execution and compliance awareness. There is no time for on-the-job learning.

All of our work has a common, fundamental change management methodology at its core — based on the philosophy that people will support what they create.

Discover The Latest Pharma News

Check out the Ceolus News


Second plant for Ceolus™ microcrystalline cellulose (MCC) in Mizushima, Japan

Ceolus™ nitrite concentration of 0.1 ppm or less

Asahi Kasei offers pharmaceutical excipient Ceolus™ with nitrite concentration of 0.1 ppm or less – Contributing to lower risk of potentially carcinogenic nitrosamine...
Ceolus™ microcrystalline cellulose

Second Plant for Ceolus™ completed

Asahi Kasei completes second plant for Ceolus™ microcrystalline cellulose Düsseldorf, New York and Tokyo, 15 February 2023 – Asahi Kasei has completed the construction...
ceolus, powder

Ceolus™ KG 1000

The most compactible microcrystalline Cellulose: Ceolus KG-1000 On behalf of Asahi, Seppic is happy to present you the most highly compactible microcrystalline...
ceolus, tablets

Second plant for Ceolus

Asahi Kasei to build a second plant for Ceolus™ microcrystalline cellulose Düsseldorf, January 18, 2021 – Asahi Kasei will build a second plant for its microcrystalline...

You Want To Reach Out To Us?

This Is The Answer To Your Questions.

Use our contact form to reach out to us. Asahi Kasei and its core operating companies have different points of contact depending on the subject of inquiry.

Our Headquarter in Europe
Fringsstraße 17, 40221 Düsseldorf

Our Headquarter in Tokyo
1 Chome-1-2 Yurakucho, Chiyoda City, Tokyo